Patents by Inventor Girija Dhamdhere

Girija Dhamdhere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Wnt compositions and methods for purification
    Patent number: 11957787
    Abstract: Disclosed herein are methods, processes, compositions, and kits for generating bone graft materials for use at a site of bone defect that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide. Also disclosed herein are methods, processes, compositions, and kits for enhancing mammalian bone marrow cells that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: April 16, 2024
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Jill Helms, Girija Dhamdhere
  • Enhancement of osteogenic potential of bone grafts
    Patent number: 11771803
    Abstract: The present invention concerns the enhancement of the osteogenic potential of bone graft by ex vivo treatment with a Wnt polypeptide, such as a liposomal Wnt polypeptide.
    Type: Grant
    Filed: January 15, 2020
    Date of Patent: October 3, 2023
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Jill Helms, Girija Dhamdhere
  • WNT COMPOSITIONS AND METHODS FOR SERUM-FREE SYNTHESIS
    Publication number: 20220325238
    Abstract: Provided herein are methods and culture systems for production of a biologically active Wnt polypeptide under a minimal serum condition. Also described herein include methods and culture systems for production of a biologically active Wnt polypeptide in a serum-free condition.
    Type: Application
    Filed: March 18, 2022
    Publication date: October 13, 2022
    Inventors: Jill Helms, Girija Dhamdhere, Bo Liu, Andrew A. Smith, Alan W. Gomez
  • WNT COMPOSITIONS AND METHODS FOR PURIFICATION
    Publication number: 20210007987
    Abstract: Disclosed herein are methods, processes, compositions, and kits for generating bone graft materials for use at a site of bone defect that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide. Also disclosed herein are methods, processes, compositions, and kits for enhancing mammalian bone marrow cells that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide.
    Type: Application
    Filed: September 22, 2020
    Publication date: January 14, 2021
    Inventors: Jill Helms, Girija Dhamdhere
  • WNT compositions and methods for purification
    Patent number: 10813884
    Abstract: Disclosed herein are methods, processes, compositions, and kits for generating bone graft materials for use at a site of bone defect that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide. Also disclosed herein are methods, processes, compositions, and kits for enhancing mammalian bone marrow cells that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: October 27, 2020
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Jill Helms, Girija Dhamdhere
  • WNT COMPOSITIONS AND METHODS FOR SERUM-FREE SYNTHESIS
    Publication number: 20200270570
    Abstract: Provided herein are methods and culture systems for production of a biologically active Wnt polypeptide under a minimal serum condition. Also described herein include methods and culture systems for production of a biologically active Wnt polypeptide in a serum-free condition.
    Type: Application
    Filed: January 27, 2017
    Publication date: August 27, 2020
    Inventors: Jill Helms, Girija Dhamdhere, Bo Liu, Andrew A. Smith, Alan W. Gomez
  • ENHANCEMENT OF OSTEOGENIC POTENTIAL OF BONE GRAFTS
    Publication number: 20200147267
    Abstract: The present invention concerns the enhancement of the osteogenic potential of bone graft by ex vivo treatment with a Wnt polypeptide, such as a liposomal Wnt polypeptide.
    Type: Application
    Filed: January 15, 2020
    Publication date: May 14, 2020
    Inventors: Jill Helms, Girija Dhamdhere
  • Enhancement of osteogenic potential of bone grafts
    Patent number: 10568989
    Abstract: The present invention concerns the enhancement of the osteogenic potential of bone graft by ex vivo treatment with a Wnt polypeptide, such as a liposomal Wnt polypeptide.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: February 25, 2020
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Jill Helms, Girija Dhamdhere
  • WNT COMPOSITIONS AND METHODS FOR PURIFICATION
    Publication number: 20180193264
    Abstract: Disclosed herein are methods, processes, compositions, and kits for generating bone graft materials for use at a site of bone defect that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide. Also disclosed herein are methods, processes, compositions, and kits for enhancing mammalian bone marrow cells that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide.
    Type: Application
    Filed: February 27, 2018
    Publication date: July 12, 2018
    Inventors: Jill Helms, Girija Dhamdhere
  • R-SPONDIN AGONIST-MEDIATED HAIR GROWTH
    Publication number: 20180161389
    Abstract: Cosmetic skin and hair care compositions for enhancing the growth and appearance of mammalian hair in an individual are provided, which compositions comprise a dose of an R-spondin agonist effective to promote anagen phase of the hair cycle.
    Type: Application
    Filed: January 8, 2016
    Publication date: June 14, 2018
    Inventors: Jill Helms, Girija Dhamdhere, Andrew A. Smith, Arie Abo, Anthony E. Oro
  • ENHANCEMENT OF OSTEOGENIC POTENTIAL OF BONE GRAFTS
    Publication number: 20180140743
    Abstract: The present invention concerns the enhancement of the osteogenic potential of bone graft by ex vivo treatment with a Wnt polypeptide, such as a liposomal Wnt polypeptide.
    Type: Application
    Filed: January 11, 2018
    Publication date: May 24, 2018
    Inventors: Jill Helms, Girija Dhamdhere
  • Wnt compositions and methods for purification
    Patent number: 9937126
    Abstract: Disclosed herein are methods, processes, compositions, and kits for generating bone graft materials for use at a site of bone defect that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide. Also disclosed herein are methods, processes, compositions, and kits for enhancing mammalian bone marrow cells that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide.
    Type: Grant
    Filed: October 2, 2014
    Date of Patent: April 10, 2018
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Jill Helms, Girija Dhamdhere
  • Enhancement of osteogenic potential of bone grafts
    Patent number: 9925304
    Abstract: The present invention concerns the enhancement of the osteogenic potential of bone graft by ex vivo treatment with a Wnt polypeptide, such as a liposomal Wnt polypeptide.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: March 27, 2018
    Assignee: The Board of Trustees of the Leland Stanford Junior Univesity
    Inventors: Jill Helms, Girija Dhamdhere
  • ENHANCEMENT OF OSTEOGENIC POTENTIAL OF BONE GRAFTS
    Publication number: 20170056556
    Abstract: The present invention concerns the enhancement of the osteogenic potential of bone graft by ex vivo treatment with a Wnt polypeptide, such as a liposomal Wnt polypeptide.
    Type: Application
    Filed: March 7, 2016
    Publication date: March 2, 2017
    Inventors: Jill Helms, Girija Dhamdhere
  • WNT COMPOSITIONS AND METHODS FOR PURIFICATION
    Publication number: 20160310424
    Abstract: Disclosed herein are methods, processes, compositions, and kits for generating bone graft materials for use at a site of bone defect that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide. Also disclosed herein are methods, processes, compositions, and kits for enhancing mammalian bone marrow cells that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide.
    Type: Application
    Filed: October 2, 2014
    Publication date: October 27, 2016
    Inventors: Jill Helms, Girija Dhamdhere
  • Enhancement of osteogenic potential of bone grafts
    Patent number: 9301980
    Abstract: The present invention concerns the enhancement of the osteogenic potential of bone graft by ex vivo treatment with a Wnt polypeptide, such as a liposomal Wnt polypeptide.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: April 5, 2016
    Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIO
    Inventors: Jill Helms, Girija Dhamdhere
  • ENHANCEMENT OF OSTEOGENIC POTENTIAL OF BONE GRAFTS
    Publication number: 20150050249
    Abstract: The present invention concerns the enhancement of the osteogenic potential of bone graft by ex vivo treatment with a Wnt polypeptide, such as a liposomal Wnt polypeptide.
    Type: Application
    Filed: July 16, 2014
    Publication date: February 19, 2015
    Inventors: Jill Helms, Girija Dhamdhere